Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | UNG | P13051 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 3/20 | 0.33 |
| ▸ | MAOB | P27338 | 3/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31044602 | 1.00 | FFAR1 (0.46) | FFAR1ALDH1A1BRD4UNGCYP2A6 | |
| SCHEMBL10633500 | 0.82 | FFAR1 (0.58) | FFAR1ALDH1A1BRD4UNGCYP2A6 | |
| SCHEMBL24835098 | 0.81 | LOX (0.32) | — | |
| SCHEMBL31574360 | 0.81 | LOX (0.32) | — | |
| SCHEMBL3614755 | 0.80 | GRM5 (0.39) | ALDH1A1GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL9699028 | 0.79 | FFAR1 (0.49) | FFAR1ALDH1A1BRD4UNGCYP2A6 | |
| SCHEMBL3735218 | 0.77 | FFAR1 (0.62) | FFAR1ALDH1A1UNGCYP2A6MAOA | |
| SCHEMBL701214 | 0.77 | CYP2A6 (0.43) | ALDH1A1BRD4CYP2A6GABRA1GABRG2 | |
| SCHEMBL29622470 | 0.77 | FFAR1 (0.62) | FFAR1ALDH1A1UNGCYP2A6MAOA | |
| SCHEMBL30409291 | 0.75 | GRM5 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | JSR CORPORATION (JP) | 2026-04-02 | — | — | US | disclosed |
| WO-2024034311-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND FILM FORMING COMPOSITION | JSR株式会社 | 2024-02-15 | — | — | WO | disclosed |
| US-11814462-B2 | Functionalized cyclic polymers and methods of preparing same | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20220056167-A1 | Functionalized Cyclic Polymers and Methods of Preparing Same | NATIONAL SCIENCE FOUNDATION | 2022-02-24 | — | — | US | disclosed |
| WO-2020223672-A1 | FUNCTIONALIZED CYCLIC POLYMERS AND METHODS OF PREPARING SAME | UNIVERSITY OF FLORIDA RESEARCHFOUNDATION, INC. (US) | 2020-11-05 | — | — | WO | disclosed |
| CN-111285874-A | RET inhibitors, pharmaceutical compositions thereof and uses thereof | 广东东阳光药业有限公司 | 2020-06-16 | — | — | CN | disclosed |
| US-20100279936-A1 | SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-11-04 | — | — | US | disclosed |
| EP-2229377-A1 | 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS | Wyeth LLC (US) | 2010-09-22 | — | — | EP | disclosed |
| WO-2010063487-A1 | PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE | MERZ PHARMA GMBH & CO. KGAA (DE) | 2010-06-10 | — | — | WO | disclosed |
| WO-2009076602-A1 | 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS | WYETH (US) | 2009-06-18 | — | — | WO | disclosed |
| US-7067653-B2 | Porphyrin Based neuton capture agents for cancer therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-06-27 | — | — | US | disclosed |
| US-20040116385-A1 | Treating and preventing viral infections with porphyrin-based compounds | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2004-06-17 | — | — | US | disclosed |
| US-20040106592-A1 | Chelation of charged and uncharged molecules with porphyrin-based compounds | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2004-06-03 | — | — | US | disclosed |
| US-20040014737-A1 | Porphyron based neuton capture agents for cancer therapy | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2004-01-22 | — | — | US | disclosed |
| WO-2001085736-A1 | PORPHYRIN-BASED NEUTRON CAPTURE AGENTS FOR CANCER THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-11-15 | — | — | WO | disclosed |
| US-5321165-A | Synthetic method for ethynylation of aromatic compounds | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1994-06-14 | — | — | US | disclosed |
| US-4587315-A | Diethynylated phenylbenzimidazole compounds | HUGHES AIRCRAFT COMPANY (US) | 1986-05-06 | — | — | US | disclosed |
| US-4537974-A | Diethynylated phenylbenzimidazole compounds | HUGHES AIRCRAFT COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| US-4465833-A | ALKYNYLATION HALOGENATED BENZENE COMPOUND IN PRESENCE OF METAL CATALYST | HUGHES AIRCRAFT COMPANY (US) | 1984-08-14 | — | — | US | disclosed |
| EP-0050428-A1 | Ethynylated aromatic compounds and process for making same | Hughes Aircraft Company (US) | 1982-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | SMC4, TYR, SMC2 | FFAR1 3731/4885ALDH1A1 2634/4885BRD4 2937/4885 |
| US-20100279936-A1 | SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES | C1R, C3AR1, PTH1R | FFAR1 232/4885ALDH1A1 1976/4885BRD4 2538/4885 |
| US-20040106592-A1 | Chelation of charged and uncharged molecules with porphyrin-based compounds | HMBS, PPOX, SLC7A1 | FFAR1 2275/4885ALDH1A1 4749/4885BRD4 1809/4885 |
| US-20040014737-A1 | Porphyron based neuton capture agents for cancer therapy | PPOX, HMBS, PYGB | FFAR1 4490/4885ALDH1A1 4029/4885BRD4 1761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.